407 related articles for article (PubMed ID: 34069635)
21. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
[TBL] [Abstract][Full Text] [Related]
22. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
23. Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells.
Sakasai-Sakai A; Takata T; Takeuchi M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660150
[TBL] [Abstract][Full Text] [Related]
24. L-Carnitine counteracts in vitro fructose-induced hepatic steatosis through targeting oxidative stress markers.
Montesano A; Senesi P; Vacante F; Mollica G; Benedini S; Mariotti M; Luzi L; Terruzzi I
J Endocrinol Invest; 2020 Apr; 43(4):493-503. PubMed ID: 31705397
[TBL] [Abstract][Full Text] [Related]
25. Pro-Inflammatory CXCR3 Impairs Mitochondrial Function in Experimental Non-Alcoholic Steatohepatitis.
Du J; Zhang X; Han J; Man K; Zhang Y; Chu ES; Nan Y; Yu J
Theranostics; 2017; 7(17):4192-4203. PubMed ID: 29158819
[TBL] [Abstract][Full Text] [Related]
26. The Alterations of Mitochondrial Function during NAFLD Progression-An Independent Effect of Mitochondrial ROS Production.
Simões ICM; Amorim R; Teixeira J; Karkucinska-Wieckowska A; Carvalho A; Pereira SP; Simões RF; Szymanska S; Dąbrowski M; Janikiewicz J; Dobrzyń A; Oliveira PJ; Potes Y; Wieckowski MR
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202179
[TBL] [Abstract][Full Text] [Related]
27. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
28. Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice.
Lohr K; Pachl F; Moghaddas Gholami A; Geillinger KE; Daniel H; Kuster B; Klingenspor M
Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694529
[TBL] [Abstract][Full Text] [Related]
29. Elevated PINK1/Parkin-Dependent Mitophagy and Boosted Mitochondrial Function Mediate Protection of HepG2 Cells from Excess Palmitic Acid by Hesperetin.
Li W; Cai Z; Schindler F; Afjehi-Sadat L; Montsch B; Heffeter P; Heiss EH; Weckwerth W
J Agric Food Chem; 2024 Jun; 72(23):13039-13053. PubMed ID: 38809522
[TBL] [Abstract][Full Text] [Related]
30. The Different Mechanisms of Lipid Accumulation in Hepatocytes Induced by Oleic Acid/Palmitic Acid and High-Fat Diet.
Zhang M; Bai X; Du Q; Xu J; Wang D; Chen L; Dong K; Chen Z; Yang J
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764494
[TBL] [Abstract][Full Text] [Related]
31. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
Im AR; Kim YH; Lee HW; Song KH
J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
[TBL] [Abstract][Full Text] [Related]
32. NEFA-induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non-alcoholic steatohepatitis.
Gao W; Du X; Lei L; Wang H; Zhang M; Wang Z; Li X; Liu G; Li X
J Cell Mol Med; 2018 Jul; 22(7):3408-3422. PubMed ID: 29602237
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
[TBL] [Abstract][Full Text] [Related]
34. The combined impact of decabromodiphenyl ether and high fat exposure on non-alcoholic fatty liver disease in vivo and in vitro.
Chen S; Che S; Li S; Ruan Z
Toxicology; 2021 Dec; 464():153015. PubMed ID: 34757160
[TBL] [Abstract][Full Text] [Related]
35. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
36. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.
Ganji SH; Kashyap ML; Kamanna VS
Metabolism; 2015 Sep; 64(9):982-90. PubMed ID: 26024755
[TBL] [Abstract][Full Text] [Related]
37. ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK- PPARα- CPT1A axis.
Dong J; Li M; Peng R; Zhang Y; Qiao Z; Sun N
J Transl Med; 2024 Feb; 22(1):196. PubMed ID: 38395901
[TBL] [Abstract][Full Text] [Related]
38. Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease.
Lee J; Park JS; Roh YS
Arch Pharm Res; 2019 Nov; 42(11):935-946. PubMed ID: 31571145
[TBL] [Abstract][Full Text] [Related]
39. Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression.
Bellanti F; Villani R; Tamborra R; Blonda M; Iannelli G; di Bello G; Facciorusso A; Poli G; Iuliano L; Avolio C; Vendemiale G; Serviddio G
Redox Biol; 2018 May; 15():86-96. PubMed ID: 29220698
[TBL] [Abstract][Full Text] [Related]
40. Benzbromarone aggravates hepatic steatosis in obese individuals.
Sun P; Zhu JJ; Wang T; Huang Q; Zhou YR; Yu BW; Jiang HL; Wang HY
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2067-2077. PubMed ID: 29526820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
